NewslettersPancreatic Cell NewsUncategorizedACY-241, an HDAC6 Inhibitor, Overcomes Erlotinib Resistance in Human Pancreatic Cancer Cells by Inducing AutophagyBy Justin.choi - November 15, 2021031Researchers evaluated the anticancer effect of ACY-241, an HDAC6-selective inhibitor, on erlotinib-resistant pancreatic cancer cells that overexpressed HDAC6.[Archives of Pharmacal Research] 6445212 AAAAAAAA items 1 apa 0 default asc 1 168911 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Abstract